integral membrane protein 2B; transmembrane protein BRI; protein E25B (ITM2B, BRI, BRI2)
Jump to navigation
Jump to search
Function
- protease inhibitor
- plays a role in APP processing regulating physiological production of beta amyloid peptide
- restricts docking of gamma-secretase to APP & access of alpha-secretase & beta-secretase to their cleavage APP sequence
- the C-terminal part of the ectodomain is processed by furin & related proteases producing a secreted peptide of 4 to 5 kD
- for the ABRI & ADAN variants, the C-terminal secreted peptide is larger & may produce amyloid fibrils responsible for neuronal dysfunction & dementia
- the remaining part of the ectodomain containing the BRICHOS domain is cleaved by ADAM10 & is secreted as a peptide of 25 kD
- the membrane-bound N-terminal fragment (NTF) of 22 kD is further proteolytically processed by SPPL2A & SPPL2B through regulated intramembrane proteolysis producing a secreted peptide (BRI2C) & an intracellular domain (ICD) released in the cytosol
- interacts with SPPL2A & SPPL2B
- interacts with APP
Structure
- homodimer; disulfide-linked
- belongs to the ITM2 family
- contains 1 BRICHOS domain
Compartment
- Golgi membrane, cell membrane
- single-pass type 2 membrane protein
Expression
expressed in brain & in other tissues
Pathology
- defects in ITM2B are a cause of
- familial British dementia via generation of ABri amyloid
- familial Danish dementia via generation of ADan amyloid
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q9Y287.html
- ↑ NIEHS-SNPs http://egp.gs.washington.edu/data/itm2b/